Text Size

Reminiscence Therapy on Depression, Self Esteem, Life Satisfaction, and Loneliness of the Elderly

This study is currently recruiting participants.
Verified May 2012 by Chinese Academy of Sciences
Sponsor:
Information provided by (Responsible Party):
Li Juan, Chinese Academy of Sciences
ClinicalTrials.gov Identifier:
NCT01553669
First received: March 6, 2012
Last updated: May 14, 2012
Last verified: May 2012
History of Changes
  Purpose

The primary hypothesis is, comparing with the control group, reminiscence therapy is significantly and clinically effective to improve the experiment group's depressive symptoms after six weeks therapy, and the efficacy can be maintained on the three months follow-up.

The secondary hypothesis is, comparing with the control group, reminiscence therapy significantly reduce the loneliness and increase the self-esteem and life satisfaction of the experiment group.


Condition Intervention Phase
Depression
 Behavioral: reminiscence therapy
 Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: The Effects of Reminiscence Therapy on Depression, Self Esteem, Life Satisfaction, and Loneliness of the Elderly in China

Resource links provided by NLM:

MedlinePlus related topics: Depression
U.S. FDA Resources

Further study details as provided by Chinese Academy of Sciences:

Primary Outcome Measures:
  • Change in depression using the Geriatric Depression Scale(GDS) [ Time Frame: the 6th and 18th week ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Change in self esteem using the Self-Esteem Scale (SES) [ Time Frame: the 6th and 18th week ] [ Designated as safety issue: Yes ]
  • Change in life satisfaction using the Life Satisfaction Index A (LSI-A) [ Time Frame: the 6th and 18th week ] [ Designated as safety issue: Yes ]
  • Change in loneliness using Russell's UCLA Loneliness Scale [ Time Frame: the 6th and 18th week ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 60
Study Start Date: October 2011
Estimated Study Completion Date: September 2012
Estimated Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: reminiscence therapy
Reminiscence therapy is a method of using the memory to protect mental health and improve the quality of life.
 Behavioral: reminiscence therapy
The subjects who are arranged to the experiment group will be intervened using the reminiscence therapy manual proposed by Watt and Cappeliez (2000). According to the manual, the group consisted of six weekly sessions of 90 min each. There will be about four people in each subgroup. During each weekly session, the memories recalled focused on a different theme.
Other Name: life review
No Intervention: Control group
The participants assigned to the waiting-list as the control group will be treated as before. After the intervention period, we will conduct reminiscence therapy on them if they ask for.

Detailed Description:

The subjects who are arranged to the experiment group will be intervened using the reminiscence therapy manual proposed by Watt and Cappeliez (2000). According to the manual, the group consisted of six weekly sessions of 90 min each. During each weekly session, the memories recalled focused on a different theme.

Data collection will occur on screening (as for baseline or pre-test), after intervention immediately (as for post-test), and three months after the intervention (as for follow-up). And outcome measures use standardized instruments with demonstrated validity and reliability:

Geriatric Depression Scale (GDS) Rosenberg self-esteem scale (SES) Life Satisfaction Index A (LSI-A) Russell's UCLA Loneliness Scale

  Eligibility

Ages Eligible for Study:   60 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. 60 years of age and older;
  2. A score above 10 and lower than 26 on the Geriatric Depression Scale (GDS);
  3. A score of 24 or higher on the Mini-Mental State Examination (MMSE);
  4. Not taking anti-depressant medication or taking part in other psychotherapy when enrolling, if taking anti-depressant medication, must be stabilized on that medication for at least three months;
  5. Having no problem with communication (such as, can speak fluent mandarin, or if he/she speaks a dialect, his/her dialect can be understood by most of people).

Exclusion Criteria:

  1. Suicide attempt;
  2. A diagnosis of cognitive impairment by DSM-Ⅳ, or mental disorders other than depression;
  3. Alcohol or drug abuse;
  4. Cannot grantee attending the therapy at a weekly base due to physical impairment, lack of time or unwilling etc.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01553669

Contacts
Contact: Tingji Chen, master (086)18610249921 Chentj@psych.ac.cn

Locations
China, Beijing
Chinese Academy of Sciences, Institute of Psychology, Center on Ageing Psychology, Key Lab of Mental Health Recruiting
Beijing, Beijing, China, 100101
Contact: Tingji Chen, master     (086)18610249921     Chentj@psych.ac.cn    
Contact: Juan Li, PhD     (086)010-64861622     lijuan@psych.ac.cn    
Principal Investigator: Juan Li, PhD            
Sponsors and Collaborators
Chinese Academy of Sciences
Investigators
Principal Investigator: Juan Li, PhD Chinese Acad Sci, Inst Psychol, Ctr Ageing Psychol, Key Lab Mental Hlth
  More Information

No publications provided by Chinese Academy of Sciences

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Li Juan, Professor, Chinese Academy of Sciences
ClinicalTrials.gov Identifier: NCT01553669     History of Changes
Other Study ID Numbers: 2009BAI77B03
Study First Received: March 6, 2012
Last Updated: May 14, 2012
Health Authority: China: Ministry of Science and Technology

Additional relevant MeSH terms:
Depression
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 19, 2013